source
- EMA releases updated guidance on drug shortage prevention plansThe European Medicines Agency has published a revised guideline aimed at helping marketing authorisation holders develop and keep drug shortage prevention plans for their products. The new guidanc…
- FDA approves Takeda’s orexin-2 drug Orzeyful for narcolepsy type 1The U.S. Food and Drug Administration has approved Takeda Pharmaceutical's new sleep medication, Orzeyful, marking the first product in the emerging orexin‑2 drug class. Orzeyful works by amplifyi…